| 向 玉,权祥菊,杨惠林,马英兰,武学海,武薇薇.定坤丹对多囊卵巢综合征患者性激素水平、胰岛素抵抗及妊娠情况的影响[J].现代生物医学进展英文版,2020,(3):578-581. |
| 定坤丹对多囊卵巢综合征患者性激素水平、胰岛素抵抗及妊娠情况的影响 |
| Effects of Dinkundan on the Sex Hormone Levels, Insulin Resistance and Pregnancy in Patients with PCOS |
| Received:July 03, 2019 Revised:July 27, 2019 |
| DOI：10.13241/j.cnki.pmb.2020.03.039 |
| 中文关键词: 定坤丹 多囊卵巢综合征 性激素 胰岛素抵抗 妊娠率 |
| 英文关键词: Dingkundan Polycystic ovary syndrome Sex hormone levels Insulin resistance The pregnancy rate |
| 基金项目:青海省科学技术厅基金项目(2016-ZJ-797) |
| Author Name | Affiliation | E-mail | | XIANG Yu | Qinghai Red Cross Hospital Reproductive Center, Xi'ning, Qinghai, 810000, China | zhangweidong198209@163.com | | QUAN Xiang-ju | Department of Obstetrics, affiliated Hospital of Qinghai University, Xi'ning, Qinghai, 810001, China | | | YANG Hui-lin | Qinghai Red Cross Hospital Reproductive Center, Xi'ning, Qinghai, 810000, China | | | MA Ying-lan | Qinghai Red Cross Hospital Reproductive Center, Xi'ning, Qinghai, 810000, China | | | WU Xue-hai | Qinghai Red Cross Hospital Reproductive Center, Xi'ning, Qinghai, 810000, China | | | WU Wei-wei | Qinghai Red Cross Hospital Reproductive Center, Xi'ning, Qinghai, 810000, China | |
|
| Hits: 1039 |
| Download times: 680 |
| 中文摘要: |
| 摘要 目的：探讨定坤丹对多囊卵巢综合征患者性激素水平、胰岛素抵抗及妊娠情况的的影响。方法：选择2016年5月至2018年5月我院收治的210例多囊卵巢综合征患者，根据随机化原则将其分为两组，每组105例。对照组患者接受达英-35与二甲双胍治疗，研究组在对照组的基础上口服定坤丹治疗。连续治疗3个月后，比较两组治疗前后的性激素水平及胰岛各相关指标的变化。治疗结束后随访1年，比较两组的排卵及妊娠情况。结果：与治疗前相比，两组治疗后的血清睾酮(Testosterone，T)、黄体生成素(Luteinizing hormone，LH)及LH/FSH均明显降低，且研究组以上指标均显著低于对照组(P＜0.05)。两组治疗前后的卵泡刺激素(Follicle-stimulating hormone，FSH)水平比较无统计学差异(P>0.05)。与治疗前相比，两组治疗后的空腹胰岛素(Fasting insulin，FINS)、餐后2 h胰岛素(Postprandial 2 hours insulin，2hPINS)及β细胞胰岛素分泌功能(Homeostasis model assessment of β cell，HOMA-β)均明显升高，胰岛素敏感指数(Homeostasis model assessment-Insulin sensitivity index，HOMA-IS)明显降低，且研究组以上指标较对照组改善更明显(P＜0.05)。研究组排卵及成功妊娠率均显著高于对照组(P＜0.05)。结论：定坤丹有助于改善多囊卵巢综合征患者性激素水平及胰岛素抵抗，提高排卵及妊娠率。 |
| 英文摘要: |
| ABSTRACT Objective: To investigate the effect of dinkundan on sex hormone level, insulin resistance and pregnancy in patients with PCOS. Methods: 210 patients with PCOS were selected as objects from May 2016 to May 2018. According to the admission single and double number, 105 patients in the control group received Da-35 and metformin therapy, and 105 patients in the study group received were treated with dinkundan orally on the basis of the control group. After continuous treatment for 3 months, the changes of sex hormone levels and islet related indicators before and after treatment in the two groups were compared,The ovulation and pregnancy of the two groups were compared after 1 year follow-up. Results: Compared with before treatment, T, LH/FSH and LH of the two groups were significantly reduced after treatment, and the experimental group was significantly lower than the control group(P<0.05). There was no statistically significant difference in FSH level between the two groups before and after treatment(P>0.05). Compared with before treatment, FINS, 2hPINS and homa-beta of the two groups were significantly increased after treatment, while homa-is was significantly decreased. Moreover, the improvement of the research group was more significant than that of the control group(P<0.05). The ovulation and successful pregnancy rates in the study group were significantly higher than those in the control group(P<0.05). Conclusion: Dinkundan helps improve sex hormone levels and patients' insulin resistance, increased ovulation and pregnancy rates, It has high application value in the treatment of PCOS. |
|
View Full Text
View/Add Comment Download reader |
| Close |
|
|
|
